|
1.
|
Actemra
|
Inf Konz 80 mg/4ml
|
Durchstf 4 ml
|
150.53
|
189.20
|
01.12.2020
|
|
|
L
|
Nein
|
58868001
|
Roche Pharma (Schweiz) AG
|
Tocilizumabum
|
19015
|
01.05.2009
|
|
|
|
|
07.15.
|
L04AC07
|
|
2.
|
Actemra
|
Inj Lös 162 mg/0.9ml
|
Fertspr 4 Stk
|
1117.12
|
1286.70
|
01.12.2020
|
|
|
L
|
Nein
|
63166001
|
Roche Pharma (Schweiz) AG
|
Tocilizumabum
|
20240
|
01.11.2014
|
|
|
|
|
07.15.
|
L04AC07
|
|
3.
|
Actemra
|
Inj Lös 162 mg/0.9ml Fertigpen
|
Fertpen 4 Stk
|
1117.12
|
1286.70
|
01.12.2020
|
|
|
L
|
Nein
|
66931001
|
Roche Pharma (Schweiz) AG
|
Tocilizumabum
|
20893
|
01.03.2019
|
|
|
|
|
07.15.
|
L04AC07
|
|
4.
|
Actemra
|
Inf Konz 200 mg/10ml
|
Durchstf 10 ml
|
376.32
|
448.40
|
01.12.2020
|
|
|
L
|
Nein
|
58868002
|
Roche Pharma (Schweiz) AG
|
Tocilizumabum
|
19015
|
01.05.2009
|
|
|
|
|
07.15.
|
L04AC07
|
|
5.
|
Actemra
|
Inf Konz 400 mg/20ml
|
Durchstf 20 ml
|
752.64
|
880.45
|
01.12.2020
|
|
|
L
|
Nein
|
58868003
|
Roche Pharma (Schweiz) AG
|
Tocilizumabum
|
19015
|
01.05.2009
|
|
|
|
|
07.15.
|
L04AC07
|